Practice Expertise
Areas of Practice
WSG Practice Industries
Profile
Lucas Maurer works as an Attorney at Law at Walder Wyss. He advises clients in the fields of commercial and corporate law, mergers & acquisitions, private equity, venture capital and financings.
Born in 1990, Lucas Maurer studied at the University of Basel (BLaw 2015, MLaw 2017). After completing his traineeship at a law firm in Basel, Lucas Maurer was admitted to the bar in 2019 in the canton of Basel-Stadt. He started his professional career as Legal & Compliance Counsel in the legal department of an international medical device company (2019 - 2022). During his studies he was further able to gain professional experience in the legal and in the compliance department of an international pharmaceutical company as well as in a renowned US law firm in New York.
Lucas Maurer practices in German and English. He also speaks French and has basic knowledge in Mandarin. He is registered with the Bar Register of the Canton of Basel-Stadt and is admitted to practice throughout Switzerland.
Born in 1990, Lucas Maurer studied at the University of Basel (BLaw 2015, MLaw 2017). After completing his traineeship at a law firm in Basel, Lucas Maurer was admitted to the bar in 2019 in the canton of Basel-Stadt. He started his professional career as Legal & Compliance Counsel in the legal department of an international medical device company (2019 - 2022). During his studies he was further able to gain professional experience in the legal and in the compliance department of an international pharmaceutical company as well as in a renowned US law firm in New York.
Lucas Maurer practices in German and English. He also speaks French and has basic knowledge in Mandarin. He is registered with the Bar Register of the Canton of Basel-Stadt and is admitted to practice throughout Switzerland.
Areas of Practice
Professional Career
Significant Accomplishments
BC Platforms Announces USD 20 Million Growth Financing led by Jolt Capital
Versant Ventures launches Vector BioPharma with USD 30m Series A
BioVersys announces successful first closing of CHF 24.2 million Series C financing to develop clinical pipeline of novel AMR therapies
Engimmune Therapeutics raises CHF 15.5m in Seed Financing
Versant Ventures launches Cimeio Therapeutics with USD 50m Series A
BC Platforms Announces USD 20 Million Growth Financing led by Jolt Capital
Versant Ventures launches Vector BioPharma with USD 30m Series A
BioVersys announces successful first closing of CHF 24.2 million Series C financing to develop clinical pipeline of novel AMR therapies
Engimmune Therapeutics raises CHF 15.5m in Seed Financing
Versant Ventures launches Cimeio Therapeutics with USD 50m Series A
Meet our Firms and Professionals
WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.
